This inventor holds 14 USPTO granted patents and 26 published patent applications, plus 6 CIPO patents and 3 EPO patents. Top assignee: Poviva Corp.. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: The Innovative Contributions of Christopher Andrew Bunka
Introduction
Christopher Andrew Bunka is a notable inventor based in Kelowna, Canada. He has made significant contributions to the fields of diabetes and epilepsy treatment through his innovative patents. With a total of 12 patents to his name, Bunka continues to push the boundaries of medical science.
Latest Patents
Bunka's latest patents include groundbreaking compositions and methods for treating diabetes. These compositions comprise GLP-1 agonists, which are effective in reducing body weight and improving triglyceride and cholesterol levels. Additionally, he has developed methods for treating type-2 diabetes, focusing on lowering A1C levels and regulating incretin hormone levels in subjects. Another significant patent involves compositions and methods for treating epilepsy, which are designed for oral delivery. These compositions include cannabidiol and CBD-containing formulations aimed at providing relief to individuals suffering from epilepsy.
Career Highlights
Throughout his career, Bunka has demonstrated a commitment to advancing medical treatments. His innovative approaches have garnered attention in the scientific community, leading to multiple patents that address critical health issues. His work not only contributes to the medical field but also enhances the quality of life for patients.
Collaborations
Bunka collaborates with talented individuals in his field, including his coworker John Docherty. These collaborations foster an environment of creativity and innovation, allowing for the development of effective treatments and solutions.
Conclusion